Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Koehler

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 18, 2015
PRO-ONKO-selection of patient-reported outcome assessments for the clinical use in cancer patients-a mixed-method multicenter cross-sectional exploratory studyHeike Schmidt, Daniela Merkel, Michael Koehler, et al.
The American Journal of the Medical Sciences|October 10, 2012
Is risk factor control and guideline-based medical therapy optimal in patients with nonobstructive coronary artery disease? A Veterans Affairs studyTarun W Dasari, Harsh Golwala, Michael Koehler, et al.
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology|May 31, 2003
Cytogenetic evolution of human ovarian cell lines associated with chemoresistance and loss of tumorigenicityStéphanie Struski, Martine Doco-Fenzy, Michael Koehler, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2022
Randomized Trial of a Supportive Psychotherapy for Parents of Adolescents and Young Adults With Hematologic MalignanciesMichael Koehler, Susanne Hoppe, Siegfried Kropf, et al.
Journal of Cancer Research and Clinical Oncology|February 25, 2017
Cell autonomous expression of CXCL-10 in JAK2V617F-mutated MPNTina M Schnöder, Judith Eberhardt, Michael Koehler, et al.
Annals of Hematology|August 7, 2017
The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark surveyClaire N Harrison, Steffen Koschmieder, Lynda Foltz, et al.
European Journal of Haematology|July 7, 2025
Final Results From a Large, Non-Interventional, Phase 4 Study of Ruxolitinib for the Treatment of Myelofibrosis in Clinical RoutineSteffen Koschmieder, Susanne Isfort, Clemens Schulte, et al.
ACS Chemical Biology|June 5, 2009
Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonistsChudi Ndubaku, Eugene Varfolomeev, Lan Wang, et al.
Scientific Reports|December 1, 2022
Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validationJens M Theysohn, Aydin Demircioglu, Malte Kleditzsch, et al.
Hemasphere|March 25, 2025
Patient and physician perceptions regarding treatment expectations and symptomatology in polycythemia vera: Insights from the Landmark 2.0 global health surveyClaire N Harrison, David M Ross, Laura Maria Fogliatto, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 18, 2015
PRO-ONKO-selection of patient-reported outcome assessments for the clinical use in cancer patients-a mixed-method multicenter cross-sectional exploratory studyHeike Schmidt, Daniela Merkel, Michael Koehler, et al.
The American Journal of the Medical Sciences|October 10, 2012
Is risk factor control and guideline-based medical therapy optimal in patients with nonobstructive coronary artery disease? A Veterans Affairs studyTarun W Dasari, Harsh Golwala, Michael Koehler, et al.
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology|May 31, 2003
Cytogenetic evolution of human ovarian cell lines associated with chemoresistance and loss of tumorigenicityStéphanie Struski, Martine Doco-Fenzy, Michael Koehler, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2022
Randomized Trial of a Supportive Psychotherapy for Parents of Adolescents and Young Adults With Hematologic MalignanciesMichael Koehler, Susanne Hoppe, Siegfried Kropf, et al.
Journal of Cancer Research and Clinical Oncology|February 25, 2017
Cell autonomous expression of CXCL-10 in JAK2V617F-mutated MPNTina M Schnöder, Judith Eberhardt, Michael Koehler, et al.
Annals of Hematology|August 7, 2017
The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark surveyClaire N Harrison, Steffen Koschmieder, Lynda Foltz, et al.
European Journal of Haematology|July 7, 2025
Final Results From a Large, Non-Interventional, Phase 4 Study of Ruxolitinib for the Treatment of Myelofibrosis in Clinical RoutineSteffen Koschmieder, Susanne Isfort, Clemens Schulte, et al.
ACS Chemical Biology|June 5, 2009
Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonistsChudi Ndubaku, Eugene Varfolomeev, Lan Wang, et al.
Scientific Reports|December 1, 2022
Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validationJens M Theysohn, Aydin Demircioglu, Malte Kleditzsch, et al.
Hemasphere|March 25, 2025
Patient and physician perceptions regarding treatment expectations and symptomatology in polycythemia vera: Insights from the Landmark 2.0 global health surveyClaire N Harrison, David M Ross, Laura Maria Fogliatto, et al.
Pageof 5